Biosimilar launches in Canada and US: Byooviz and Stimufend
BYOOVIZ▽™(ranibizumab)
Byooviz: Ophthalmology's First Biosimilar - PIE
First Ophthalmology Biosimilar Approved in the United States
Biogen, Samsung Bioepis launch USFDA approved BYOOVIZ in US
BYOOVIZ - Biogen MA Inc. Trademark Registration
Europe has its first Lucentis biosimilar, Samsung Bioepis' Byooviz
BYOOVIZ™
FDA approves Byooviz, first ophthalmology biosimilar
AAO Spokesperson: FDA Approval of Byooviz, First Biosimilar to
Expanding Your Toolbox With Biosimilars - Retina Today
Byooviz